Metagenomi Therapeutics, Inc. (MGX) Operating income 2023–2025
Metagenomi Therapeutics, Inc. (MGX) annual operating income history from SEC filings — each fiscal year as reported.
-$96.0MFY2025 · since FY2023: -$78.5M → -$96.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$96.0M | -8.0% |
| FY2024 | -$88.9M | -13.3% |
| FY2023 | -$78.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice